CN2274962Y - Leak-proof skin permeating plaster - Google Patents

Leak-proof skin permeating plaster Download PDF

Info

Publication number
CN2274962Y
CN2274962Y CN 96218285 CN96218285U CN2274962Y CN 2274962 Y CN2274962 Y CN 2274962Y CN 96218285 CN96218285 CN 96218285 CN 96218285 U CN96218285 U CN 96218285U CN 2274962 Y CN2274962 Y CN 2274962Y
Authority
CN
China
Prior art keywords
layer
medicine
diadermic
transdermal
antiseepage
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN 96218285
Other languages
Chinese (zh)
Inventor
丁铁岭
林平
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN 96218285 priority Critical patent/CN2274962Y/en
Application granted granted Critical
Publication of CN2274962Y publication Critical patent/CN2274962Y/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Medicinal Preparation (AREA)

Abstract

The utility model relates to an anti-leakage diadermic plaster used for treating human body diseases, which is a diadermic administration plaster. The dosage form utilizes skin as a portal of inputting the medicine into systematic circulation, the medicine penetrates the skin and directly enters the blood circulation to exert the therapy function. The utility model is characterized in that a polygonal anti-leakage diadermic administration system clamped between a coating layer and a back lining layer is formed by that an anti-leakage layer is fixed on the back lining layer, an anti-leakage ring is arranged on the anti-leakage layer, a diadermic framework layer is arranged in the anti-leakage ring, and the diadermic framework layer is provided with a medicine layer. The diadermic framework layer uses the bioenergy effect to enhance the diadermic absorptivity of the medicine, and solves the problems of small medicine loading and low bioavailability of external medicine dosage forms.

Description

The antiseepage transdermal patch
This utility model relates to a kind of antiseepage transdermal patch that is used for the treatment of human body diseases, it is a kind of percutaneous administration patch, a kind of external used medicine dosage form by intact skin, this dosage form utilizes skin as medicine input body circulation door, makes medicine see through skin and directly enters blood circulation and bring into play therapeutical effect.
The dosage form of percutaneous dosing has plaster, ointment, paste, membrane, powder, patch or the like at present.The drug loading of unguentum is bigger, and bioavailability of medicament is low, if coloured unguentum also pollutes underwear easily, and brings many inconveniences to shower.The transdermal absorption factor of powder is very low, and it is confined to contain the volatile component medicine, and other medicines then are difficult to see through keratodermatitis, makes the medical material waste bigger.The drug loading of membrane plaster is little, and the active ingredient loss of decolouring back is bigger, has directly influenced therapeutic effect.
The purpose of this utility model is a kind of antiseepage transdermal patch of developing at above deficiency, its transdermal casing play, adopt far-infrared radiation material, as pharmaceutical carrier, improve the transdermal absorption factor of medicine with its bioenergy effect, little to solve above various external used medicine dosage form drug loading, the problem that bioavailability is low.
This utility model is achieved in that the antiseepage transdermal patch comprises cover layer 1 and backing layer 3, the formation of the polygon antiseepage transdermal drug delivery system 2 that wherein clamps between cover layer 1 and the backing layer 3 is, be fixed with impervious barrier 5 on the backing layer 3, antiseepage circle 4 is contained on the impervious barrier 5, transdermal casing play 6 is housed in the antiseepage circle 4, medicine layer 7 is housed on the transdermal casing play 6.
This utility model can be achieved in that also the number of plies of transdermal casing play 6 can be 1 layer, also can be multilamellar, and the shape of polygon antiseepage transdermal drug delivery system 2 can be circular, also can be square.
Good effect of the present utility model is:
1, the transdermal casing play of this product has heat effect and resonance effect, the transdermal absorption factor and the bioavailability of medicine have been improved, promoted local microcirculation effectively, changed the barrier properties of transdermal zone skin, the metabolism exchange process of skin tissue cell is accelerated, improve the transdermal absorption factor of plaster, strengthened the dynamics of clinical treatment.
2, the medicine layer of adorning on the transdermal casing play of this product can be looked the state of an illness, and position carrier band unguentum, powder, paste or the liquid preparation of focus use very convenient.
3, this utility model novel structure, onset is rapid, curative effect is reliable, and dosage form is easy to use, is convenient to store and carry, and not only drug loading is big for it, and nothing is overflowed, seepage, does not pollute underwear.
4, a kind of hepatitis antiseepage transdermal patch that utilizes this utility model to make reaches 94.39% through the clinical observation total effective rate.
5, following clinical efficacy with table 1 explanation hepatitis antiseepage transdermal patch and matched group GANFUKANG Umbilical therapeutic bag.
Table 1 clinical efficacy statistics
Grouping The example number Clinical basic healing Produce effects Effectively Invalid
Hepatitis antiseepage transdermal patch 107 ?41(38.32%) 46(42.99%) 14(13.08%) 6(5.61%)
The GANFUKANG Umbilical therapeutic bag 30 ?2(6.67%) 21(70.00%) ?5(16.67%) 2(6.67%)
Description of drawings:
Fig. 1 is a structural representation of the present utility model.
Fig. 2 is the novel another kind of structural representation of this reality.
Wherein:
1, cover layer 2, polygon antiseepage transdermal drug delivery system 3, backing layer
4, antiseepage circle 5, impervious barrier 6, transdermal casing play 7, medicine layer
Below the utility model is described in further detail in conjunction with the accompanying drawings.
As shown in Figure 1, 2.The formation of antiseepage transdermal patch is: clamped polygon antiseepage transdermal drug delivery system 2 between cover layer 1 and backing layer 3, its formation is, be fixed with impervious barrier 5 on the backing layer 3, antiseepage circle 4 is contained on the impervious barrier 5, transdermal casing play 6 is housed in the antiseepage circle 4, medicine layer 7 is contained on the transdermal casing play 6, and backing layer 3 is to adopt medical air-permeable adhesive plaster or pressure sensitive adhesive or plastic-aluminum pressure sensitive glue composite material.Fixedly impervious barrier 5 and antiseepage circle 4 are not only in its effect, but also play plaster are sticked on effect on the skin, and transdermal casing play 6 and medicine layer 7 are not come off.Impervious barrier 5 is oil removal, water proof material, and its effect is to prevent water solublity or the outside seepage of fat-soluble medicine, pollutes underwear.The effect of the antiseepage circle 4 of dress is to prevent water solublity or fat capacitive medicine to peripheral seepage on the impervious barrier 5, pollutes underwear.Transdermal casing play 6 is to adopt the composite with the effect of fortune infra-red radiation, it can increase interatomic quantity of motion, the subcutaneous deep temperature is risen, telangiectasis, blood circulation quickens, thereby has improved the percutaneous absorption rate of medicine, has improved bioavailability of medicament, it can look the size of drug loading, places 1 layer or 2 layers or multilamellar.Medicine layer 7 is that it can be various unguentum, as Chinese medicine fluid extract, paste, powder and various liquid preparation in order to treatment or medicine layer for health care.The material of cover layer 1 is paper products or textile or plastic foil, and its effect has been the covering effect, can prevent effectively that medicine layer 7 from polluting.
This utility model is used for when clinical, can select the antiseepage transdermal patch of suitable shape according to the state of an illness, throws off cover layer 1, medicine layer 7 is sticked on the condition of illness part or the place, acupuncture point gets final product.

Claims (3)

1, a kind of antiseepage transdermal patch, comprise cover layer (1) and backing layer (3), it is characterized in that: the formation of the polygon antiseepage transdermal drug delivery system (2) that clamps between cover layer (1) and the backing layer (3) is, be fixed with impervious barrier (5) on the backing layer (3), antiseepage circle (4) is contained on the impervious barrier (5), transdermal casing play (6) is housed in the antiseepage circle (4), medicine layer (7) is housed on the transdermal casing play (6).
2, antiseepage transdermal patch according to claim 1 is characterized in that: the number of plies of transdermal casing play (6) is one deck, or multilamellar.
3, antiseepage transdermal patch according to claim 1 is characterized in that: the shape of polygon antiseepage transdermal drug delivery system (2) is circular, or square.
CN 96218285 1996-08-28 1996-08-28 Leak-proof skin permeating plaster Expired - Fee Related CN2274962Y (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN 96218285 CN2274962Y (en) 1996-08-28 1996-08-28 Leak-proof skin permeating plaster

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN 96218285 CN2274962Y (en) 1996-08-28 1996-08-28 Leak-proof skin permeating plaster

Publications (1)

Publication Number Publication Date
CN2274962Y true CN2274962Y (en) 1998-02-25

Family

ID=33899176

Family Applications (1)

Application Number Title Priority Date Filing Date
CN 96218285 Expired - Fee Related CN2274962Y (en) 1996-08-28 1996-08-28 Leak-proof skin permeating plaster

Country Status (1)

Country Link
CN (1) CN2274962Y (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101262824B (en) * 2005-06-17 2011-06-29 奥尔蒂治疗学公司 Permeant delivery system and methods for use thereof
CN102283744A (en) * 2010-06-21 2011-12-21 许思东 Paste for treating cold stuffy nose by being acted on Tiantu acupoint of anterior jugular fossa
CN106177845A (en) * 2016-08-10 2016-12-07 张成莲 Palace disease patch

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101262824B (en) * 2005-06-17 2011-06-29 奥尔蒂治疗学公司 Permeant delivery system and methods for use thereof
CN102283744A (en) * 2010-06-21 2011-12-21 许思东 Paste for treating cold stuffy nose by being acted on Tiantu acupoint of anterior jugular fossa
CN106177845A (en) * 2016-08-10 2016-12-07 张成莲 Palace disease patch

Similar Documents

Publication Publication Date Title
AU2011101745A4 (en) Transdermal patch
CN105833333A (en) Nursing pad with antibacterial, itching relieving and disinfection functions and method for manufacturing nursing pad
CN2274962Y (en) Leak-proof skin permeating plaster
CN1175427A (en) Traditional Chinese medicine spray and ointment gauze for treatment of wound
CN2479998Y (en) Anti osmosis magnetic plaster
CN113694010A (en) Production process of microneedle transdermal patch
CN1231243C (en) Medicinal recipe for treating rheumatalgia and treating method
CN1178686C (en) Ointment for wound healing
CN201959273U (en) Novel plaster capable of promoting blood circulation and relieving pains
CN2140759Y (en) Adhesive plaster
CN2845785Y (en) Medicinal moxibustion plaster
CN200951154Y (en) Paper diaper trousers for medical or health-care use
CN1444951A (en) Exterior Chinese medicine Oil-in-Water (O/W) type prescription for reduce swelling and ease pain and its preparing method
CN209611792U (en) A kind of honey plaster
CN212756831U (en) Traditional Chinese medicine collapsed package
CN215084143U (en) Five-toe socks for treating beriberi
CN2530663Y (en) Portable wet-dressing medicine pad
CN2388965Y (en) Breast ointment
CN2152571Y (en) Multifunctional perfume quick-acting health pad
CN105878977A (en) Ginger and periostracum cicada composition and applications thereof
CN1326548C (en) Medicine for treating gonorrhoea
CN2245997Y (en) Fixed wall of human body acupoint skin feeding medicine preparation
CN113750080A (en) Special patch for breast directional drug penetration and use method
CN206045013U (en) A kind of new external omphaloidean ointment plaster
CN203139080U (en) Traditional Chinese medicine constitution health preserving acupuncture point press sticker

Legal Events

Date Code Title Description
C14 Grant of patent or utility model
GR01 Patent grant
C19 Lapse of patent right due to non-payment of the annual fee
CF01 Termination of patent right due to non-payment of annual fee